Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Combination of Nilotinib and Pegylated Interferon Alfa-2B Results in High Rates of MR4.5 at 24 Months - Primary Analysis of the ALLG CML 11 Pinnacle Study

Blood (2019) 134 (Supplement_1): 2926.

https://doi.org/10.1182/blood-2019-125740

Published: 2019

Journal Articles

Thrombin Generation in Nephrotic Syndrome Is Dependent on Remission Status and Hypercholestrolemia

Bryce Kerlin, Amanda P. Waller, PhD, Jonathan P. Troost, PhD, Samir Parikh, MD, William E. Smoyer, MD, Matthias Kretzler, MD

Blood (2019) 134 (Supplement_1): 2422.

https://doi.org/10.1182/blood-2019-128680

Published: 2019

Journal Articles

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Ljupco Veskovski, MD, Per-Ola Andersson, MD PhD, Ingemar Turesson, MD PhD, Daniel Malmodin, PhD, Anders Pedersen, PhD, Ulf-Henrik Mellqvist, MD PhD

Blood (2019) 134 (Supplement_1): 1771.

https://doi.org/10.1182/blood-2019-121961

Published: 2019

Journal Articles

Polyunsaturated Fatty Acid (PUFA) Signaling Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma

Cristina Panaroni, PhD, Keertik Fulzele, PhD, Rosemary Soucy, Cherrie Huang, Kenta Mukaihara, MD PhD, Shrikanta Chattopadhyay, MBBS, Noopur S. Raje, MD

Blood (2019) 134 (Supplement_1): 3108.

https://doi.org/10.1182/blood-2019-131906

Published: 2019

Journal Articles

Ruxolitinib Can Lead to Weight Gain in Patients with Myeloproliferative Neoplasms By Uncoupling Feeding from Central Leptin Signaling Via JAK2/STAT3

Spencer Krichevsky, BS, Pouneh Kermani, PhD, Nicole Molle, BS, Richard T. Silver, MD, Andrew I. Schafer, MD, Ellen K. Ritchie, MD, Joseph Scandura, MD PhD

Blood (2018) 132 (Supplement 1): 4284.

https://doi.org/10.1182/blood-2018-99-119542

Published: 2018

Journal Articles

Arachidonic Acid Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma

Cristina Panaroni, PhD, Keertik Fulzele, PhD, Rosemary Soucy, Ka Tat Siu, PhD, Kenta Mukaihara, MD PhD, Cherrie Huang, Shrikanta Chattopadhyay, MBBS, Noopur Raje, MD

Blood (2018) 132 (Supplement 1): 4498.

https://doi.org/10.1182/blood-2018-99-118482

Published: 2018

Journal Articles

Identification of High Serum Apolipoprotein A1 As a Favorable Prognostic Indicator in Patients with Multiple Myeloma

Peng Liu, MD, Lifan Liang, Jing Li, MD

Blood (2018) 132 (Supplement 1): 5589.

https://doi.org/10.1182/blood-2018-99-110919

Published: 2018

Journal Articles

Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study

Blood (2018) 132 (Supplement 1): 459.

https://doi.org/10.1182/blood-2018-99-110569

Published: 2018

Journal Articles

Metabolic Profile & Body Composition in Egyptian Children with Transfusion-Dependent Egyptian B-Thalassemia

Mohsen Saleh Elalfy, MD, Fatma Soliman Elsayed Ebeid, MD MRCPCH, El Gendy Yasmin, MD, Elghamry Islam, MD, Kalifa Amna, MBBCh

Blood (2018) 132 (Supplement 1): 4903.

https://doi.org/10.1182/blood-2018-99-114260

Published: 2018

Journal Articles

Low Serum Cholesterol Levels Predict Inferior Prognosis in Diffuse Large B Cell Lymphoma

Rui Gao, MD, Wei Xu, MDPhD, Jin-Hua Liang, MD, Li Wang, MD, Lei Fan, MD PhD, Tao Yang, MD PhD, Jianyong Li, MD PhD

Blood (2017) 130 (Supplement 1): 2849.

https://doi.org/10.1182/blood.V130.Suppl_1.2849.2849

Published: 2017

Journal Articles

Nilotinib in Combination with Pegylated Interferon Alfa-2b for CP-CML Leads to High Molecular Response Rates: Interim Results of the Pinnacle Study

Blood (2017) 130 (Supplement 1): 2898.

https://doi.org/10.1182/blood.V130.Suppl_1.2898.2898

Published: 2017

Journal Articles

Utility of Fluorodeoxyglucose Positron Emission Tomography(FDG-PET) and Biomarkers, Serum Vitamin B12 and HDL for Assessing Lymphoproliferation in Children and Adults with Autoimmune Lymphoproliferative Syndrome Due to FAS Mutations (ALPS-FAS)

V. Koneti Rao, MD, Susan Price, Lori Dodd, Remaley Alan, Millie Whatley, Jorge Carrasquillo, MD, Clara C. Chen, MD

Blood (2016) 128 (22): 4891.

https://doi.org/10.1182/blood.V128.22.4891.4891

Published: 2016

Journal Articles

Cardiometabolic and Hemostatic Profiles of Women Carriers of Hemoglobin Variants Using Combined Oral Contraceptives

Junia Raquel Dutra Ferreira, MSc, Caroline Conceição Guarda, MSc, Rayra Pereira Santiago, MSc, Luane Rocha, Graduated, Jessica SANTOS Ferreira, Graduated, Luís Araújo, Graduated, Barbara Mota, Graduated, Thassila Nogueira Pitanga, PhD, Milena Magalhães Milena, MSc, Magda Seixas Carvalho, PhD, Elisangela Vitoria Adorno, PhD, Marilda Souza Goncalves, PhD

Blood (2016) 128 (22): 4851.

https://doi.org/10.1182/blood.V128.22.4851.4851

Published: 2016

Journal Articles

Circulating Microvesicle Number, Function and Small RNA Content Vary with Age, Gender, Lipid, Hormone Profile and Smoking Status

Anoop Enjeti, Anita Ariyarajah, Angel D'Crus, Michael Seldon, Lisa Lincz

Blood (2016) 128 (22): 4951.

https://doi.org/10.1182/blood.V128.22.4951.4951

Published: 2016

Journal Articles

Genetic Deletion of CCRL2 Impairs Macrophage Accumulation in Arterial Intima and Attenuates Atherosclerotic Plaque Development

Yiren Cao, MD, Fei Yang, MS, Chaojun Tang, PhD, Shuhong Hu, MS, Brian Anthony Zabel, PhD, Li Zhu, MD PhD

Blood (2015) 126 (23): 2239.

https://doi.org/10.1182/blood.V126.23.2239.2239

Published: 2015

Journal Articles

Atherosclerotic Cardiovascular Risk in Adult Patients with Hemophilia: What We Can Do to Reduce Risk of Cardiovascular Events? Implementation of 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol in Patients with Hemophilia

Kamila Izabela Cisak, MD, Jianmin Pan, PhD, Shesh Nath Rai, PhD, Patricia Ashby, ARNP, Vivek R. Sharma, MD FACP

Blood (2015) 126 (23): 4687.

https://doi.org/10.1182/blood.V126.23.4687.4687

Published: 2015

Journal Articles

Deranged Serum Fasting Lipid Profile in Children and Adolescent with Thalassemia Major

Sadia Sultan, MBBS, FCPS, Syed Mohammed Irfan, MBBS, FCPS, FACP, Rozina Zeeshan, MBBS

Blood (2014) 124 (21): 4899.

https://doi.org/10.1182/blood.V124.21.4899.4899

Published: 2014

Journal Articles

Obesity and Insulin Resistance after Chemotherapy in Patients with Acute Lymphoblastic Leukemia

Yesim Oymak, MD, Belgin Uysal, MD, Tuba Hilkay Karapinar, MD, Yilmaz Ay, MD, Dilek Ince, MD PhD, Bengu Demirag, MD, Burcak Tatli Gunes, MD, Esin Albudak Ozcan, MD, Ersin Toret, MD, Sultan Aydin Koker, MD, Neryal Muminoglu, MD, Canan Vergin, MD, Korcan Demir, MD

Blood (2014) 124 (21): 5250.

https://doi.org/10.1182/blood.V124.21.5250.5250

Published: 2014

Journal Articles

A Link Between Hypercholesterolemia and Chronic Lymphocytic Leukemia

Signy Chow, MD FRCPC, Rena Buckstein, MD FRCPC, David Spaner, MD FRCPC, PhD

Blood (2014) 124 (21): 5630.

https://doi.org/10.1182/blood.V124.21.5630.5630

Published: 2014

Journal Articles

Palmitic Acid, As Verified Using Lipid Profiling By Secondary Ion Mass Spectrometry, Demonstrates Anti-Tumor Activity Against Multiple Myeloma

Yasuyuki Nagata, MD, Itsuko Ishizaki, Michihiko Waki, Yoshimi Ide, MD PhD, Md Amir Hossen, Kazunori Ohnishi, MD PhD, Mitsutoshi Setou, MD PhD

Blood (2014) 124 (21): 5683.

https://doi.org/10.1182/blood.V124.21.5683.5683

Published: 2014

NARROW

Combination of Nilotinib and Pegylated Interferon Alfa-2B Results in High Rates of MR4.5 at 24 Months - Primary Analysis of the ALLG CML 11 Pinnacle Study

Thrombin Generation in Nephrotic Syndrome Is Dependent on Remission Status and Hypercholestrolemia

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Polyunsaturated Fatty Acid (PUFA) Signaling Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma

Ruxolitinib Can Lead to Weight Gain in Patients with Myeloproliferative Neoplasms By Uncoupling Feeding from Central Leptin Signaling Via JAK2/STAT3

Arachidonic Acid Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma

Identification of High Serum Apolipoprotein A1 As a Favorable Prognostic Indicator in Patients with Multiple Myeloma

Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study

Metabolic Profile & Body Composition in Egyptian Children with Transfusion-Dependent Egyptian B-Thalassemia

Low Serum Cholesterol Levels Predict Inferior Prognosis in Diffuse Large B Cell Lymphoma

Nilotinib in Combination with Pegylated Interferon Alfa-2b for CP-CML Leads to High Molecular Response Rates: Interim Results of the Pinnacle Study

Utility of Fluorodeoxyglucose Positron Emission Tomography(FDG-PET) and Biomarkers, Serum Vitamin B12 and HDL for Assessing Lymphoproliferation in Children and Adults with Autoimmune Lymphoproliferative Syndrome Due to FAS Mutations (ALPS-FAS)

Cardiometabolic and Hemostatic Profiles of Women Carriers of Hemoglobin Variants Using Combined Oral Contraceptives

Circulating Microvesicle Number, Function and Small RNA Content Vary with Age, Gender, Lipid, Hormone Profile and Smoking Status

Genetic Deletion of CCRL2 Impairs Macrophage Accumulation in Arterial Intima and Attenuates Atherosclerotic Plaque Development

Atherosclerotic Cardiovascular Risk in Adult Patients with Hemophilia: What We Can Do to Reduce Risk of Cardiovascular Events? Implementation of 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol in Patients with Hemophilia

Deranged Serum Fasting Lipid Profile in Children and Adolescent with Thalassemia Major

Obesity and Insulin Resistance after Chemotherapy in Patients with Acute Lymphoblastic Leukemia

A Link Between Hypercholesterolemia and Chronic Lymphocytic Leukemia

Palmitic Acid, As Verified Using Lipid Profiling By Secondary Ion Mass Spectrometry, Demonstrates Anti-Tumor Activity Against Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only